| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.3 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |